Amy Goundry/LinkedIn
Feb 18, 2026, 12:34
Amy Goundry: Which Are The Next Major Advances in Blood and Plasma-Driven Immune Regulation?
Amy Goundry, Managing Editor at Sage, shared on LinkedIn:
”The blood–immune interface is a dynamic space where cellular and plasma components regulate immune responses across infection, inflammation, and systemic disease.
At Blood and Plasma we’re particularly interested in rigorous mechanistic research in this area, and we’ve just opened a Special Collection on it.
Which area of immune regulation by blood or plasma components will drive the next major advances?
- Cellular crosstalk – How interactions among erythrocytes, platelets, leukocytes, and endothelium regulate immune activation and resolution
- Plasma-mediated immune modulation – How complement, antibodies, cytokines, metabolites, and extracellular vesicles shape immune cell phenotype and function
- Early biomarkers of dysregulation – Identifying markers that detect immune imbalance early and improve risk stratification and therapeutic targeting
- Inflammation–coagulation links – How immune activation and coagulation pathways intersect in thrombosis, sepsis, and systemic inflammatory disease
Vote — and share what trends you’re seeing in your field!”

Stay updated on all scientific advances with Hemostasis Today.
-
Oct 5, 2026, 15:00Serena Williams and Pulmonary Embolism: From Personal Crisis to Lessons in Venous Thromboembolism
-
Oct 5, 2026, 14:55Marco Moscarelli: 3D Reconstruction Enhances Volumetric Assessment of Post-TAVI Thrombosis
-
Oct 5, 2026, 13:24Abdul Muqtadir Abbasi: Diagnostic Pearls for Evaluating Isolated Thrombocytopenia in Residents
-
Oct 5, 2026, 13:16Katerina Pavenski: Rethinking What ‘Normal’ Means for Iron Deficiency
-
Oct 5, 2026, 13:09Rick Matthews: Balancing Established VTE Partnerships with Innovative Interventional Technologies
-
Oct 5, 2026, 13:01Nawsherwan Mohammad: Recognizing TTP Before the ADAMTS13 Result Arrives
-
Oct 5, 2026, 12:51Bruno Pougault: The Hidden Challenges Behind Anti Xa Testing
-
Oct 5, 2026, 12:41Syed Huzaifa Khan: Rethinking CTRP12 as a Biomarker for In Stent Restenosis
-
Oct 5, 2026, 12:29Mirvat Alasnag: Creating a Space for Women in Cardiovascular Medicine